EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 205 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2016. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $579,000 | +12.6% | 18,349 | +0.4% | 0.02% | +7.1% |
| Q2 2016 | $514,000 | -17.2% | 18,271 | +6.9% | 0.01% | -6.7% |
| Q1 2016 | $621,000 | +18.1% | 17,086 | +30.1% | 0.02% | +15.4% |
| Q4 2015 | $526,000 | +40.3% | 13,136 | -0.1% | 0.01% | +44.4% |
| Q3 2015 | $375,000 | -43.9% | 13,151 | -35.1% | 0.01% | -40.0% |
| Q2 2015 | $668,000 | -83.9% | 20,272 | -86.0% | 0.02% | -84.0% |
| Q1 2015 | $4,160,000 | -55.5% | 144,658 | -57.8% | 0.09% | -55.5% |
| Q4 2014 | $9,343,000 | +46.1% | 343,102 | +14.3% | 0.21% | +42.6% |
| Q3 2014 | $6,395,000 | +69.6% | 300,080 | +78.8% | 0.15% | +64.4% |
| Q2 2014 | $3,770,000 | -59.7% | 167,836 | -54.7% | 0.09% | -19.6% |
| Q1 2014 | $9,362,000 | +9.6% | 370,462 | -0.3% | 0.11% | +12.0% |
| Q4 2013 | $8,540,000 | +134.4% | 371,432 | +94.2% | 0.10% | +11.1% |
| Q3 2013 | $3,644,000 | +38.0% | 191,311 | +4.5% | 0.09% | +28.6% |
| Q2 2013 | $2,640,000 | – | 183,075 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Values First Advisors, Inc. | 152,699 | $519,178 | 0.34% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 299,187 | $1,017,000 | 0.22% |
| Hilltop Holdings Inc. | 235,019 | $799,064 | 0.09% |
| AIMZ Investment Advisors, LLC | 51,372 | $174,665 | 0.08% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 868,605 | $2,953,257 | 0.07% |
| PALISADE CAPITAL MANAGEMENT, LP | 509,325 | $1,731,705 | 0.05% |
| SHERBROOKE PARK ADVISERS LLC | 41,417 | $140,818 | 0.04% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 2,428,490 | $8,256,866 | 0.03% |
| Y-Intercept (Hong Kong) Ltd | 75,362 | $256,231 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,246,020 | $4,236,468 | 0.02% |